Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

✍ Scribed by Barry Trachtenberg; Darcy L. Velazquez; Adam R. Williams; Ian McNiece; Joel Fishman; Kim Nguyen; Didier Rouy; Peter Altman; Richard Schwarz; Adam Mendizabal; Behzad Oskouei; John Byrnes; Victor Soto; Melissa Tracy; Juan Pablo Zambrano; Alan W. Heldman; Joshua M. Hare

• Book ID: 116192380
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 322 KB
• Volume: 161
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2010.11.024